| A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis (NCT06295692) | Janssen Pharmaceutical K.K. | 2024-02-09 |
| A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa (NCT05926583) | Janssen Pharmaceutical K.K. | 2023-09-12 |
| A Study of Erdafitinib Intravesical Delivery System in Japanese Participants With Bladder Cancer (NCT05567185) | Janssen Pharmaceutical K.K. | 2023-03-03 |
| A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension (NCT05167825) | Janssen Pharmaceutical K.K. | 2022-11-14 |
| A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants (NCT05242432) | Janssen Pharmaceutical K.K. | 2022-04-01 |
| A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants (NCT05159128) | Janssen Pharmaceutical K.K. | 2021-11-15 |
| A Study of JNJ-77242113 in Healthy Japanese and Chinese Participants (NCT05062200) | Janssen Pharmaceutical K.K. | 2021-10-25 |
| A Study of Amivantamab in Participants With Previously Treated Advanced or Metastatic Gastric or Esophageal Cancer (NCT04945733) | Janssen Pharmaceutical K.K. | 2021-08-30 |
| An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa (NCT04868916) | Janssen Pharmaceutical K.K. | 2021-07-26 |
| A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice (NCT04963725) | Janssen Pharmaceutical K.K. | 2021-07-18 |
| A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT04773522) | Janssen Pharmaceutical K.K. | 2021-05-20 |
| A Study of JNJ-67953964 in Healthy Japanese Adult Male Participants (NCT04791332) | Janssen Pharmaceutical K.K. | 2021-04-30 |
| A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan (NCT04459507) | Janssen Pharmaceutical K.K. | 2021-03-22 |
| A Study of Guselkumab in Participants With Systemic Sclerosis (NCT04683029) | Janssen Pharmaceutical K.K. | 2021-02-24 |
| A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT04696809) | Janssen Pharmaceutical K.K. | 2021-02-22 |
| A Study of JNJ-61393215 in Healthy Japanese Male Participants (NCT04713930) | Janssen Pharmaceutical K.K. | 2021-01-29 |
| A Study of JNJ-40411813 in Healthy Japanese Male Participants (NCT04677530) | Janssen Pharmaceutical K.K. | 2021-01-29 |
| A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD) (NCT04630145) | Janssen Pharmaceutical K.K. | 2021-01-08 |
| A Study of Ad26.COV2.S in Adults (COVID-19) (NCT04509947) | Janssen Pharmaceutical K.K. | 2020-08-11 |
| A Study of Macitentan, in Healthy Japanese Male Participants (NCT04500808) | Janssen Pharmaceutical K.K. | 2020-07-21 |
| A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (NCT04397263) | Janssen Pharmaceutical K.K. | 2020-06-10 |
| A Study to Evaluate the Single Vaccination of an Adenovirus Serotype 26 Pre-Fusion F (Ad26.preF) Based Respiratory Syncytial Virus (RSV) Vaccine in Japanese Adults Aged 60 Years and Older (NCT04354480) | Janssen Pharmaceutical K.K. | 2020-05-15 |
| A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma (NCT04325828) | Janssen Pharmaceutical K.K. | 2020-04-07 |
| A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults (NCT04306302) | Janssen Pharmaceutical K.K. | 2020-03-13 |
| A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM) (NCT04062448) | Janssen Pharmaceutical K.K. | 2019-09-25 |
| A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan (NCT04034095) | Janssen Pharmaceutical K.K. | 2019-07-08 |
| A Study of JNJ-64530440 in Healthy Japanese Male Participants (NCT03915886) | Janssen Pharmaceutical K.K. | 2019-04-15 |
| A Study of JNJ-63733657 in Healthy Japanese Participants (NCT03689153) | Janssen Pharmaceutical K.K. | 2018-09-28 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers (NCT03547037) | Janssen Pharmaceutical K.K. | 2018-08-31 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants (NCT03618160) | Janssen Pharmaceutical K.K. | 2018-08-06 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants (NCT03536325) | Janssen Pharmaceutical K.K. | 2018-05-31 |
| A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD) (NCT03474679) | Janssen Pharmaceutical K.K. | 2018-05-01 |
| Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) (NCT02895815) | Janssen Pharmaceutical K.K. | 2018-04-09 |
| A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers (NCT03398876) | Janssen Pharmaceutical K.K. | 2017-12-22 |